PRKN and neoplasm: Parkin ISGylation induced by type I IFN promotes the ubiquitin E3 ligase activity of parkin, thereby increasing the protective effect of parkin against IFN-induced cell death59, suggesting the double-edged roles of type I IFN-induced protein ISGylation in controlling tumor progression or tumor suppression.